Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (331-340 of 442) with videos related to

Pageof 45
Sort By:
Cell Reports|December 16, 2021
Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody bindingDhiraj Mannar, James W Saville, Xing Zhu, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
Plos One|May 27, 2015
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 AntibodiesZheng Yang, Jingjing Li, Qingsheng Liu, et al.
Scientific Reports|August 20, 2016
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionAnurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
International Journal of Biological Sciences|June 19, 2018
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cellsZhizhen Chen, Jie Liu, Dafeng Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Constitutive cell surface association between CD4 and CCR5X Xiao, L Wu, T S Stantchev, et al.
Journal of Virology|May 14, 2005
Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virusKatharine N Bossart, Gary Crameri, Antony S Dimitrov, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Pageof 45

Showing results (331-340 of 442) with videos related to

Sort By:
Pageof 45
Cell Reports|December 16, 2021
Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody bindingDhiraj Mannar, James W Saville, Xing Zhu, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
Plos One|May 27, 2015
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 AntibodiesZheng Yang, Jingjing Li, Qingsheng Liu, et al.
Scientific Reports|August 20, 2016
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionAnurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
International Journal of Biological Sciences|June 19, 2018
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cellsZhizhen Chen, Jie Liu, Dafeng Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Constitutive cell surface association between CD4 and CCR5X Xiao, L Wu, T S Stantchev, et al.
Journal of Virology|May 14, 2005
Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virusKatharine N Bossart, Gary Crameri, Antony S Dimitrov, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Pageof 45